$HOWL

Werewolf Therapeutics, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA

HOWL chart

What traders are saying about $HOWL

Latest posts

Werewolf Therapeutics, Inc. news

Werewolf Therapeutics, Inc. key financials

USD2025202420232022
Net income-$60.8M-$70.5M-$37.4M-$53.8M
Diluted EPS$-1.33$-1.63$-1.05$-1.86
Total assets (year end)$69.4M$126.9M$174.8M$160.2M
Cash and equivalents (year end)$57.0M$111.0M$134.3M$129.3M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 10-K10-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K

About Werewolf Therapeutics, Inc.

Ticker
HOWL (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Waltham, MA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1785530

Frequently asked questions

What exchange is Werewolf Therapeutics, Inc. listed on?

Werewolf Therapeutics, Inc. trades on the Nasdaq under the ticker symbol HOWL.

What industry is Werewolf Therapeutics, Inc. in?

Werewolf Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Werewolf Therapeutics, Inc. headquartered?

Werewolf Therapeutics, Inc.'s business address on file with the SEC is in Waltham, MA.

When does Werewolf Therapeutics, Inc.'s fiscal year end?

Werewolf Therapeutics, Inc.'s fiscal year ends on December 31.